Publications by authors named "Kosuke Arita"

Claim this Profile
D
Development of an explainable machine learning model to reproduce and interpret expert pharmacological decisions in osteoporosis treatment.
Yutaro Sugawara, Tomohiro Shimizu, Hotaka Ishizu, Kosuke Arita, Yusuke Ohashi

Bone· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic profiling of osteoblasts on hydroxyapatite-coated-metal-surface reveals enhanced osteogenic and angiogenic processes relevant to accelerated bone healing.
Yuki Ogawa, Kosuke Arita, Takayuki Nonoyama, Kano Sato, Ryota Watanabe

Biomater Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracolumbar kyphosis prognoses poor results after proximal femoral fracture: a 3-year multicenter prospective cohort study.
Yutaro Sugawara, Hotaka Ishizu, Kosuke Arita, Tetsuro Oue, Komei Sato

J Bone Miner Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary fracture and mortality risk with very high fracture risk osteoporosis and proximal femoral fracture.
Hotaka Ishizu, Tomohiro Shimizu, Kosuke Arita, Komei Sato, Renya Takahashi

J Bone Miner Metab· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients.
Tetsuro Oue, Tomohiro Shimizu, Tsuyoshi Asano, Shun Shimodan, Hotaka Ishizu, Kosuke Arita

Calcif Tissue Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid arthritis is a risk factor for refracture in patients with fragility fractures.
Hotaka Ishizu, Hirokazu Shimizu, Tomohiro Shimizu, Taku Ebata, Yuki Ogawa, Kosuke Arita

Mod Rheumatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients.
Tomohiro Shimizu, Kosuke Arita, Eihiro Murota, Shigeto Hiratsuka, Ryo Fujita

J Bone Miner Metab· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks vs. benefits of switching therapy in patients with postmenopausal osteoporosis.
Hotaka Ishizu, Kosuke Arita, Mohamad Alaa Terkawi, Tomohiro Shimizu, Norimasa Iwasaki

Expert Rev Endocrinol Metab· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis